According to the latest announcement, the authorised share capital remained at 20,000,000,000 ordinary shares with a par value of HKD0.01 each, totaling HKD200,000,000. The balance of issued shares also stayed at 13,132,082,051, with no treasury shares reported.
The announcement indicates no new share issuance, repurchases, or transfers under the 2024 Share Option Scheme or the 2024 Share Incentive Scheme during November. The perpetual subordinated convertible securities remained at US$88,461,539, reflecting a potential right to convert into 690,000,000 ordinary shares at HKD1 each, though no conversions took place in the reporting period.
All details were authorized by the board and comply with applicable regulations. The document was submitted on 1 December 2025.